Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Barratt

Showing results (231-240 of 272) with videos related to

Pageof 28
Sort By:
Wellcome Open Research|October 23, 2018
Protocol and rationale for the first South Asian 5-year prospective longitudinal observational cohort study and biomarker evaluation investigating the clinical course and risk profile of IgA nephropathy: GRACE IgANI cohortSuceena Alexander, George T John, Anila Korula, et al.
The New England Journal of Medicine|November 6, 2025
A Phase 3 Trial of Atacicept in Patients with IgA NephropathyRichard Lafayette, Sean J Barbour, Robert M Brenner, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
Individualized treatment effects of corticosteroids in IgA nephropathyDavid L Hoelscher, Nikolas Ej Schmitz, Leon Niggemeier, et al.
Science Translational Medicine|July 1, 2016
Low α-defensin gene copy number increases the risk for IgA nephropathy and renal dysfunctionZhen Ai, Ming Li, Wenting Liu, et al.
Lancet (London, England)|June 4, 2026
Atrasentan in patients with IgA nephropathy (ALIGN): final 2·5-year results from a randomised, double-blind, placebo-controlled, phase 3 trialHiddo J L Heerspink, Meg J Jardine, Donald E Kohan, et al.
The New England Journal of Medicine|November 10, 2025
Sibeprenlimab in IgA Nephropathy - Interim Analysis of a Phase 3 TrialVlado Perkovic, Hernán Trimarchi, Vladimir Tesar, et al.
Kidney International|January 6, 2020
The authors replyEdmund J Lamb, Alice J Sitch, Jonathan Barratt, et al.
Kidney International|May 16, 2019
Biological variation of measured and estimated glomerular filtration rate in patients with chronic kidney diseaseCeri Rowe, Alice J Sitch, Jonathan Barratt, et al.
Pediatric Nephrology (Berlin, Germany)|September 27, 2024
IPNA clinical practice recommendations for the diagnosis and management of children with IgA nephropathy and IgA vasculitis nephritisMarina Vivarelli, Susan Samuel, Rosanna Coppo, et al.
Health Technology Assessment (Winchester, England)|July 26, 2024
Accuracy of glomerular filtration rate estimation using creatinine and cystatin C for identifying and monitoring moderate chronic kidney disease: the eGFR-C studyEdmund J Lamb, Jonathan Barratt, Elizabeth A Brettell, et al.
Pageof 28

Showing results (231-240 of 272) with videos related to

Sort By:
Pageof 28
Wellcome Open Research|October 23, 2018
Protocol and rationale for the first South Asian 5-year prospective longitudinal observational cohort study and biomarker evaluation investigating the clinical course and risk profile of IgA nephropathy: GRACE IgANI cohortSuceena Alexander, George T John, Anila Korula, et al.
The New England Journal of Medicine|November 6, 2025
A Phase 3 Trial of Atacicept in Patients with IgA NephropathyRichard Lafayette, Sean J Barbour, Robert M Brenner, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
Individualized treatment effects of corticosteroids in IgA nephropathyDavid L Hoelscher, Nikolas Ej Schmitz, Leon Niggemeier, et al.
Science Translational Medicine|July 1, 2016
Low α-defensin gene copy number increases the risk for IgA nephropathy and renal dysfunctionZhen Ai, Ming Li, Wenting Liu, et al.
Lancet (London, England)|June 4, 2026
Atrasentan in patients with IgA nephropathy (ALIGN): final 2·5-year results from a randomised, double-blind, placebo-controlled, phase 3 trialHiddo J L Heerspink, Meg J Jardine, Donald E Kohan, et al.
The New England Journal of Medicine|November 10, 2025
Sibeprenlimab in IgA Nephropathy - Interim Analysis of a Phase 3 TrialVlado Perkovic, Hernán Trimarchi, Vladimir Tesar, et al.
Kidney International|January 6, 2020
The authors replyEdmund J Lamb, Alice J Sitch, Jonathan Barratt, et al.
Kidney International|May 16, 2019
Biological variation of measured and estimated glomerular filtration rate in patients with chronic kidney diseaseCeri Rowe, Alice J Sitch, Jonathan Barratt, et al.
Pediatric Nephrology (Berlin, Germany)|September 27, 2024
IPNA clinical practice recommendations for the diagnosis and management of children with IgA nephropathy and IgA vasculitis nephritisMarina Vivarelli, Susan Samuel, Rosanna Coppo, et al.
Health Technology Assessment (Winchester, England)|July 26, 2024
Accuracy of glomerular filtration rate estimation using creatinine and cystatin C for identifying and monitoring moderate chronic kidney disease: the eGFR-C studyEdmund J Lamb, Jonathan Barratt, Elizabeth A Brettell, et al.
Pageof 28